Cargando…
Evaluation of pregnancy outcomes using medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist in ovarian stimulation: A retrospective cohort study
BACKGROUND: Limited studies have compared pregnancy outcomes with medroxyprogesterone acetate (MPA) vs. gonadotropin-releasing hormone antagonist (GnRH antagonist) in ovarian stimulation protocols. The results show heterogeneity. OBJECTIVE: This study aims to assess pregnancy outcomes with the use o...
Autores principales: | Singh, Ekika, Blockeel, Christophe, Singh, Madhulika, Gupta, Rishi, Kamdi, Sandesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Knowledge E
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358237/ https://www.ncbi.nlm.nih.gov/pubmed/35958960 http://dx.doi.org/10.18502/ijrm.v20i6.11445 |
Ejemplares similares
-
Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone
Antagonist for the Prevention of Premature Luteinizing Hormone Surge in
hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI
Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023) -
Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023) -
The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development
por: Wen, Xiaowei, et al.
Publicado: (2018) -
Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016) -
Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
por: Rabati, Behnaz Khani, et al.
Publicado: (2012)